American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

Frontline segment on supplement safety skewed and misleading

AHPA Update

Regulated supplement industry has long history of advocating for strong enforcement of current law.

AHPA and UNPA launch campaign to educate state attorneys general

AHPA Update

Joint campaign will develop working relationships with state attorneys general (AG) and educate state AGs about the herbal supplement industry.

AHPA submits comments to improve Dietary Supplement Label Database

AHPA Update

AHPA reiterates encouragement for voluntary submission of labels to federal database

Industry Associations Welcome Elevation of Division of Dietary Supplement Programs to 'Office' within FDA

Press Release

The five trade associations representing the dietary supplement industry today welcomed the elevation of the Division of Dietary Supplement Programs (DDSP) to an "Office" status within the Food and Drug Administration's (FDA) Center for Food Safety and Applied Nutrition (CFSAN).

Product safety expert debunks research questioning the safety of dietary supplements at Congressional briefing

Press Release

Research purporting to raise significant questions regarding the safety of dietary supplements often lacks context and appropriate data to draw meaningful conclusions

Goldenseal and Aloe vera "non-decolorized whole leaf extract" added to California Proposition 65 list

AHPA Update

Companies generally have one year to ensure products comply with new Proposition 65 requirements

AHPA expresses opposition to mandatory product registration

AHPA restates recommendation to submit labels to existing federal database

"The existing Dietary Supplement Label Database is an effective platform to provide consumers with the same type of information that would be provided by mandatory product registration," said AHPA President Michael McGuffin.

AHPA joins coalition opposing proposed revision to Prop 65 lead safe harbor

OEHHA proposal is problematic from both a policy and scientific standpoint

AHPA joined a coalition to express concerns about OEHHA's proposed revisions to the Proposition 65 safe harbor Maximum Allowable Dose Levels (MADLs) for lead

AHPA Provides Perspective on Emergency Room Visits Purportedly Associated with Supplements

When placed into context, study demonstrates relative safety of supplements

Article published in New England Journal of Medicine

overstates emergency room (ER) visits associated with dietary supplements. Study also shows supplements are relatively safe compared to other product categories.

AHPA urges USP to use more precise terminology in proposed general chapter

AHPA Update

AHPA expresses concern that USP's proposal confuses unlawful misbranded drugs with legal dietary supplements
RSS
123456

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.